BLAUVELT, A. .; WOLLENBERG, A.; PINK, A.; PERIS, K. .; ARMSTRONG , A.; SPELMAN, L.; SAEKI, H.; LYNDE, C.; HERRANZ, P.; BARBAROT, S.; SIMPSON, E. Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s57, 2021. DOI: 10.25251/skin.5.supp.57. Disponível em: https://jofskin.org/index.php/skin/article/view/1408. Acesso em: 11 aug. 2022.